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Autophagy is postulated to play a role in antivi-
ral innate immunity. However, it is unknown
whether viral evasion of autophagy is important
in disease pathogenesis. Here we show that the
herpes simplex virus type 1 (HSV-1)-encoded
neurovirulence protein ICP34.5 binds to the
mammalian autophagy protein Beclin 1 and in-
hibits its autophagy function. A mutant HSV-1
virus lacking the Beclin 1-binding domain of
ICP34.5 fails to inhibit autophagy in neurons
and demonstrates impaired ability to cause
lethal encephalitis in mice. The neurovirulence
of this Beclin 1-binding mutant virus is restored
in pkr/ mice. Thus, ICP34.5-mediated antag-
onism of the autophagy function of Beclin 1 is
essential for viral neurovirulence, and the anti-
viral signaling molecule PKR lies genetically
upstream of Beclin 1 in host defense against
HSV-1. Our findings suggest that autophagy in-
hibition is a novel molecular mechanism by
which viruses evade innate immunity and cause
fatal disease.
INTRODUCTION
Autophagy is an evolutionarily conserved process in
which the cell packages cytosolic constituents in a dou-
ble-membrane vesicle and delivers them to the lysosome
for degradation (Levine and Klionsky, 2004). The digestion
of intracellular contents by autophagy provides metabolic
substrates during periods of starvation, contributes to tis-
sue remodeling during differentiation and development,
and removes protein aggregates and superfluous or dam-
aged organelles. The dysregulation of autophagy mayCelcontribute to a number of diseases, including neurode-
generative disorders, aging, cancer, and infectious dis-
eases (Shintani and Klionsky, 2004; Mizushima, 2005).
The first link between infection and autophagy, de-
scribed in 1978, was the electronmicroscopic (EM) visual-
ization of herpes simplex virus type 1 (HSV-1) and cyto-
megalovirus virions inside autophagosomes (Smith and
deHarven, 1978). For decades thereafter, further evidence
remained limited to EMobservations of viruses and bacte-
ria in autophagosome-like structures, colocalization of
viruses and bacteria with endosomal/lysosomal and ER
markers, or chemical manipulation of the autophagy path-
way (Kirkegaard et al., 2004). More recently, the identifica-
tion of evolutionarily conserved genes required for autoph-
agy (Tsukada and Ohsumi, 1993, Thumm et al., 1994) has
led to a growingbodyofmolecular evidence indicating that
cells deploy the autophagic machinery in defense against
invading microorganisms (xenophagy) (Levine, 2005;
Deretic, 2006; Schmid et al., 2006; Amano et al., 2006).
Xenophagy is important in innate immunity against viral
infections (Kirkegaard et al., 2004; Seay et al., 2005;
Levine, 2006). Neuronal overexpression of themammalian
autophagy protein Beclin 1 protects mice against lethal
Sindbis virus encephalitis (Liang et al., 1998). In plants,
the autophagy genes BECLIN 1, ATG3, and ATG7
decrease viral replication and prevent the spread of pro-
grammed cell death during the tobacco mosaic virus-
induced hypersensitive response (HR) (Liu et al., 2005).
The antiviral, interferon-inducible PKR signaling pathway
promotes autophagy in response to HSV-1 infection,
and the HSV-1 neurovirulence protein ICP34.5 antago-
nizes this response (Tallo´czy et al., 2002). These latter
findings raise the possibilities that autophagy may also
protect against HSV-1 infection and that HSV-1 ICP34.5-
mediated blockade of autophagy may contribute to viral
neurovirulence. However, the role of HSV-1 or other viral
antagonism of autophagy in viral pathogenesis is not
yet known.l Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inc. 23
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HSV-1 encephalitis. HSV-1, a 152 kb double-stranded
DNA virus in the a-herpesvirus family, is an important hu-
man pathogen. It is the most common cause of sporadic
encephalitis, with high rates of mortality and chronic neu-
rological impairment in survivors (Tyler, 2004). The mouse
model of HSV-1 encephalitis has provided important clues
regarding the molecular determinants of HSV-1 neuro-
logic disease. Most notably, Chou et al. first demonstrated
that the virally encoded protein ICP34.5 is required for
neurovirulence in mice (Chou et al., 1990). ICP34.5 is
also required for neurologic disease in humans, since an
ICP34.5-deleted virus can be used safely as an oncolytic
agent to treat high-grade gliomas (Harrow et al., 2004).
ICP34.5 contains a GADD34 homology region (Chou
and Roizman, 1994) that reverses eIF2a phosphorylation
by recruiting protein phosphatase-1a (He et al., 1997).
This observation has led to the proposal that ICP34.5
may function in neurovirulence by blocking eIF2a kinase
signaling-dependent host translational arrest (Chou and
Roizman, 1994). However, substitution of the correspond-
ing domain from the murine homolog of GADD34 into
ICP34.5 maintains the ability of HSV-1 to reverse eIF2a
phosphorylation and prolong viral protein synthesis in vitro
but results in a virus that is attenuated in vivo (He et al.,
1996;Markovitz et al., 1997). Moreover, a second-sitemu-
tation in an ICP34.5-disrupted virus resulting in immedi-
ate-early expression of the US11 gene product restores
the ability of the virus to reverse eIF2a phosphorylation
and host-cell shutoff (Mulvey et al., 1999) but fails to re-
store neurovirulence (Mohr et al., 2001). Therefore, factors
in addition to inhibition of host-cell translational shutoff
likely contribute to ICP34.5-mediated neurovirulence.
In this study, we found that the HSV-1 ICP34.5 neurovir-
ulence protein directly interacts with the mammalian au-
tophagy protein Beclin 1. Beclin 1 was originally discov-
ered in a yeast two-hybrid screen using Bcl-2 as a bait
(Liang et al., 1998). Beclin 1 and its yeast ortholog, Atg6,
are part of a class III PI3 kinase complex that recruits other
autophagy proteins to the preautophagosomalmembrane
(Kihara et al., 2001a, 2001b). Orthologs of Beclin 1 regu-
late diverse homeostatic and developmental processes
in model organisms (Levine and Klionsky, 2004). Beclin
1-mediated autophagy may also protect against different
mammalian diseases, including Huntington’s disease
(Shibata et al., 2006; Jia et al., 2007), cancer (Liang
et al., 1999; Qu et al., 2003; Yue et al., 2003; Degenhardt
et al., 2006), and viral infections (Levine, 2006).
To investigate the functional significance of the HSV-1-
ICP34.5/Beclin 1 interaction, we examined the ability of
wild-type and Beclin 1-binding-deficient ICP34.5 mutants
to antagonize Beclin 1-mediated autophagy in yeast and
mammalian cells. Our results show that ICP34.5 can spe-
cifically antagonize Beclin 1-mediated autophagy and that
the Beclin 1-binding domain, but not the GADD34 domain,
is essential for this function. Furthermore, we show that
a Beclin 1-binding-deficient ICP34.5 mutant virus is neu-
roattenuated in mice, suggesting that the ICP34.5/Beclin
1 interaction plays an important role in the pathogenesis24 Cell Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inof fatal HSV-1 encephalitis. The neurovirulence of this
virus is restored in pkr/ mice, providing genetic evi-
dence for PKR-mediated autophagy in protection against
HSV-1 disease. Our findings identify an as yet undefined
mechanism of virulence: targeting of the autophagic
machinery by a virally encoded protein.
RESULTS
HSV-1 ICP34.5 Inhibits Beclin 1-Dependent
Autophagy in Yeast
In a yeast two-hybrid screen using HSV-1 ICP34.5 as
a bait, one of the ICP34.5-interacting proteins identified
was the mammalian autophagy protein Beclin 1 (B. Roiz-
man, personal communication). Our laboratory confirmed
that HSV-1 ICP34.5 interacts with human Beclin 1 in
a yeast two-hybrid assay (Figure 1A). Unlike the interac-
tion between Beclin 1 and cellular and viral Bcl-2 proteins
(Pattingre et al., 2005; Liang et al., 2006), the N-terminal
half of Beclin 1 is not sufficient for the interaction between
Beclin 1 and ICP34.5. Full-length human Beclin 1, but not
a truncation mutant encoded by nucleotides 1–708, binds
to HSV-1 ICP34.5. Thus, the a-herpesvirus-encoded pro-
tein ICP34.5 binds to a region of Beclin 1 that is distinct
from the region of Beclin 1 targeted by viral Bcl-2 proteins
encoded by g-herpesviruses.
Although mammalian Beclin 1 interacts with ICP34.5 in
yeast, the yeast ortholog of Beclin 1, Atg6, does not inter-
act with HSV-1 ICP34.5 (Figure 1A). Therefore, we used
yeast disrupted of ATG6 to examine the effects of
ICP34.5 on Beclin 1-dependent autophagy. Wemeasured
autophagy by quantitative DIC microscopy of yeast fol-
lowing nitrogen starvation (Figures 1B and 1C). As re-
ported previously (Liang et al., 1999; Melendez et al.,
2003; Pattingre et al., 2005), human beclin 1 transforma-
tion restores starvation-induced autophagy in autoph-
agy-defective atg6 null yeast. However, cotransformation
of ICP34.5 with beclin 1 abrogates the ability of Beclin 1 to
rescue starvation-induced autophagy, decreasing levels
to those observed in autophagy-deficient atg6D yeast
(Figure 1B; p < 0.0001, Student’s t test). ICP34.5 has no
effect on the ability of ATG6 transformation to rescue
autophagy in atg6D yeast. Taken together, these results
indicate that ICP34.5 is likely to inhibit autophagy by bind-
ing to Beclin 1.
ICP34.5 Inhibits Beclin 1-Dependent Autophagy
in Mammalian Cells
Next, we sought to confirm the interaction between HSV-1
ICP34.5 and Beclin 1 in mammalian cells. In HEK293 cells
transiently transfected with plasmids expressing Flag epi-
tope-tagged Beclin 1 and HSV-1 ICP34.5, we found that
Flag-Beclin 1 coimmunoprecipitated with ICP34.5 and
that ICP34.5 coimmunoprecipitated with Flag-Beclin 1
(Figure 2A), indicating that Beclin 1 and ICP34.5 can inter-
act in mammalian cells. To determine whether ICP34.5
does interact with endogenous Beclin 1 in virally infected
cells, we performed coimmunoprecipitation studies of
HSV-1-infected wild-type (beclin 1+/+) embryonic stemc.
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Autophagy Inhibition and HSV-1 NeurovirulenceFigure 1. ICP34.5 Inhibits Beclin 1-Dependent Autophagy in Yeast
(A) Yeast two-hybrid interactions of ICP34.5 and Beclin 1. +, positive reaction within 8 hr; , lack of positive reaction at 24 hr. Nucleotide position of
genes fused to plasmid is indicated next to human beclin 1 constructs.
(B) Quantitation of starvation-induced autophagy in atg6D yeast transformedwith plasmids indicated below the x axis. Results represent mean ± SEM
for triplicate samples. For each sample, a minimum of 100 cell profiles were analyzed, and cell profiles with one or more autophagosome within the
vacuole were scored as positive. Similar results were obtained in five independent experiments.
(C) Representative DIC photomicrographs of atg6D yeast transformed with indicated plasmids following starvation for 4 hr. Arrows denote represen-
tative autophagosomes.(ES) cells and HSV-1-infected ES cells containing a homo-
zygous null mutation in beclin 1 (beclin 1/) (Figure 2B).
We found that ICP34.5 coimmunoprecipitates with Beclin
1 in HSV-1-infected beclin 1+/+ ES cells. No specific bands
were observed in HSV-infected beclin 1/ ES cells or in
wild-type, beclin 1+/+ ES cells infected with a previously
characterized mutant strain of HSV-1 (17termA) (Bolovan
et al., 1994) deleted of the entire ICP34.5 gene (Figure
2B). Thus, ICP34.5 interacts with endogenous Beclin 1 in
virally infected mammalian cells.
To examine whether ICP34.5 antagonizes the autoph-
agy function of Beclin 1 in mammalian cells, we used
MCF7 human breast carcinoma cells stably transfected
with human beclin 1 (MCF7.beclin 1 cells) or MCF7 cells
stably transfected with empty vector (MCF7.control cells)
(Liang et al., 2001). MCF7 cells express low levels of en-
dogenous Beclin 1 and fail to increase autophagic activity
in response to starvation unless Beclin 1 is ectopically ex-
pressed (Liang et al., 1999, 2001; Pattingre et al., 2005;
Furuya et al., 2005). Therefore, we assessed the effects
of HSV-1 ICP34.5 on the ability of beclin 1 to rescue
autophagy in MCF7 cells (Figures 2C and 2D).
To measure autophagy, we used the fluorescent au-
tophagy marker GFP-LC3, which forms punctate dots
upon proteolytic processing and lipidation during autoph-Celagy (Kabeya et al., 2000) (Figure 2D). Similar to previous
reports, we found that MCF7.control cells fail to increase
their autophagy activity in response to amino acid starva-
tion, whereas MCF7.beclin 1 cells undergo a significant
increase in autophagic activity following starvation (p =
0.003 for MCF7.beclin 1 cells in normal media versus star-
vation media, Student’s t test) (Figure 2C). Transfection of
an ICP34.5 expression plasmid significantly decreased
starvation-induced autophagy in MCF7.beclin 1 cells
(p = 0.008, Student’s t test) (Figure 2C). These data
demonstrate that ICP34.5 can inhibit Beclin 1-dependent
autophagy in mammalian cells.
Amino Acids 68–87 of ICP34.5 Are Required
for Beclin 1 Binding and Inhibition
of Beclin 1-Dependent Autophagy
Next, we performed a structure-function analysis to map
the domain of ICP34.5 responsible for binding to Beclin
1 and inhibition of Beclin 1-dependent autophagy. To ac-
complish this, we performed coimmunoprecipitations of
MCF7.beclin 1 cells transfected with different myc-tagged
ICP34.5 constructs and also assessed the ability of these
ICP34.5 constructs to inhibit starvation-induced auto-
phagy in MCF7.beclin 1 cells.l Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inc. 25
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Mammalian Cells and Inhibits Beclin
1-Mediated Autophagy
(A) Coimmunoprecipitation of Flag-tagged Be-
clin 1 with ICP34.5 in HEK293 cells transfected
with the indicated plasmids.
(B) Coimmunoprecipitation of endogenous Be-
clin 1 with ICP34.5 in beclin 1+/+ or beclin 1/
mouse ES cells infected with the indicated
virus.
(C) Quantitation of autophagy, as measured by
GFP-LC3 punctations, in MCF7 cells trans-
fected with plasmids expressing Beclin 1
and/or ICP34.5 during growth in normal media
(open bars) or starvationmedia (filled bars). Re-
sults represent mean ± SEM for triplicate sam-
ples. For each sample, a minimum of 100 cells
was analyzed. Similar results were obtained in
five independent experiments.
(D) Representative photomicrographs of im-
ages used for quantitative analyses in (C).
Arrow denotes representative punctate GFP-
LC3 dot corresponding to an autophagosome.ICP34.5 contains an N-terminal region, followed
by a tripeptide repeat, and a C-terminal GADD34 homol-
ogy domain (Figure 3A). Previous studies have shown
that the GADD34 domain binds protein phosphatase-1a
to dephosphorylate eIF2a and block eIF2a kinase
signaling-dependent host-cell shutoff during HSV-1 in-
fection (He et al., 1997). We found that wild-type
ICP34.5 and ICP34.5 lacking the GADD34 domain
(ICP34.5DGADD34) both immunoprecipitated with Flag-
Beclin 1 in MCF7.beclin 1 cells (Figure 3B). The lower
levels of ICP34.5DGADD34 that coimmunoprecipitate
with Beclin 1 are likely due to lower levels of expression
of the ICP34.5DGADD34 protein (Figure 3B, see upper
panel) rather than actual differences in binding affinity.
Thus, the GADD34 domain of ICP34.5 that is required
for antagonism of eIF2a phosphorylation is dispensable
for Beclin 1 binding.
To further characterize the GADD34-independent inter-
action between ICP34.5 and Beclin 1, we constructed26 Cell Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier InICP34.5 mutants containing 20 amino acid deletions in
the N-terminal half of the protein. Three ICP34.5 deletion
mutants resulted in stable protein expression and could
be used for further analyses, including mutants deleted
of amino acids 48–67, 68–87, or 88–107 (herein referred
to as ICP34.5D48–67, ICP34.5D68–87, and ICP34.5D88–
107, respectively) (Figure 3B, and data not shown). Of
these three deletion mutants, ICP34.5D48–67 and
ICP34.5D88–107, but not ICP34.5D68–87, coimmunopre-
cipitated with Beclin 1 (Figure 3B, and data not shown).
This indicates that deletion of the region spanning amino
acids 68–87 (but not deletions of similar length in nearby
flanking regions) abolishes the interaction between
ICP34.5 and Beclin 1.
To evaluate the effect of ICP34.5 binding to Beclin 1 on
Beclin 1-dependent, starvation-induced autophagy, we
cotransfectedMCF7.beclin 1 cells with plasmids express-
ing HSV-1 ICP34.5 mutants and the autophagosome
marker GFP-LC3 (Figure 3C). Consistent with the abilityc.
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of ICP34.5 Is Required for Beclin 1 Bind-
ing and Inhibition of Autophagy
(A) Schematic representation of ICP34.5 show-
ing position of Beclin 1-binding region (amino
acids 68–87) and GADD34 homology region.
(B) Coimmunoprecipitation of Myc-tagged
wild-type or indicated mutant ICP34.5 and
Flag-tagged Beclin 1 in MCF7.beclin 1 cells.
(C) Quantitation of autophagy, as measured by
GFP-LC3 punctate regions in MCF7.beclin 1
cells transfected with the indicated HSV-1
ICP34.5 plasmids during growth in normal me-
dia (open bars) or starvation media (filled bars).
Results represent mean ± SEM for triplicate
samples. For each sample, a minimum of 100
cells was analyzed. Similar results were ob-
tained in three independent experiments.of ICP34.5DGADD34 to coimmunoprecipitate with Beclin
1 inMCF7.beclin 1 cells, HSV-1 ICP34.5DGADD34 inhibits
autophagy in these cells as effectively as wild-type
ICP34.5 (p = 0.3364, Student’s t test). Similarly, the 20
amino acid deletion mutants that retain the ability to inter-
act with Beclin 1 (ICP34.5D48–67 and ICP34.5D88–107)
also inhibit starvation-induced autophagy (p = 0.4833,
Student’s t test). In contrast, the mutant ICP34.5D68–87,
which is unable to coimmunoprecipitate with Beclin 1, fails
to inhibit starvation-induced autophagy in MCF7.beclin 1
cells (p = 0.0028, Student’s t test). This demonstrates
that amino acids 68–87 are required not only for binding
to Beclin 1 but also for inhibition of Beclin 1-dependent au-
tophagy. The GADD34 domain of ICP34.5 is dispensable
for this autophagy-inhibitory activity, suggesting that
ICP34.5 can modulate host-cell functions through its
interactions with Beclin 1 in a protein phosphatase-1a-
independent manner.
Amino Acids 68–87 of ICP34.5 Are Not Required for
Viral Growth In Vitro, Viral Blockade of eIF2a
Phosphorylation, or Viral Blockade
of Host-Cell Shutoff
To assess the functional significance of ICP34.5 inhibition
of Beclin 1-mediated autophagy during viral infection, weCeconstructed a mutant HSV-1 virus containing a deletion of
amino acids 68–87 in ICP34.5 (referred to as HSV-1
34.5D68–87) and a marker rescue control (referred to as
HSV-1 34.5D68–87R) (Figure S1 in the Supplemental
Data available with this article online). HSV-1 34.5D68–
87 expresses a protein of the predicted molecular weight
(24.5 kDa) that reacts with a polyclonal anti-ICP34.5 anti-
body (Figure 4A). However, no ICP34.5D68–87 mutant
protein coimmunoprecipitates with Beclin 1, indicating
that deletion of amino acids 68–87 blocks the ability of
ICP34.5 to bind to Beclin 1 in virally infected cells. The
ICP34.5 protein expressed by the marker rescue virus
HSV-1 34.5D68–87R coimmunoprecipitates with Beclin
1, confirming that the lack of interaction between
ICP34.5D68–87 and Beclin 1 is not due to extragenic
mutations.
In contrast to a mutant HSV-1 virus lacking the entire
ICP34.5 gene (HSV-1 17termA), which displays a growth
defect (Chou et al., 1990), HSV-1 34.5D68–87 replicates
to the same levels as the wild-type marker rescue HSV-1
strain (HSV-1 34.5D68–87R) in human SK-N-SH neuro-
blastoma cells (Figure 4B). Previous studies have pro-
posed that ICP34.5 is required for growth in SK-N-SH cells
because of its ability to block virus-induced host-cell shut-
off by dephosphorylating eIF2a. The mapping of thisll Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inc. 27
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of ICP34.5 Is Dispensable for ICP34.5-
Mediated Blockade of Host-Cell Shutoff
(A) Coimmunoprecipitation of endogenous
Beclin 1with ICP34.5 in SK-N-SH cells infected
with HSV-1 DICP34.5 (17termA) or its marker
rescue virus (17termAR), or HSV-1 34.5D68–
87 or its marker rescue (HSV-1 34.5D68–87R).
(B) Viral replication of HSV-1 34.5D68–87 and
HSV-1 34.5D68–87R in SK-N-SH neuroblas-
toma cells. Data shown represent mean ±
SEM geometric titer.
(C) Western blot detection of the serine 51
phosphorylated form of eIF2a in SK-N-SH neu-
roblastoma cells 16 hr after infection with the
indicated virus.
(D) 35S-labeled cellular proteins in SK-N-SH
cells 16 hr after infection with the indicated
virus.function of ICP34.5 to the GADD34 domain (which is not
required for Beclin 1 binding), together with the wild-
type levels of viral growth in HSV-1 34.5D68–87-infected
SK-N-SH cells, suggested that HSV-1 34.5D68–87 should
behave similarly to wild-type HSV-1 with respect to block-
ade of eIF2a phosphorylation and host-cell shutoff. In-
deed, we found that HSV-1 34.5D68–87 blocked eIF2a
serine 51 phosphorylation as effectively as its marker res-
cue control virus (HSV-1 34.5D68–87R) whereas signifi-
cant eIF2a serine 51 phosphorylation was observed in
SK-N-SH cells infected with HSV-1 17termA (Figure 4C).
Furthermore, this blockade of eIF2a phosphorylation cor-
related with the ability of HSV-1 34.5D68–87 to maintain
protein synthesis in virally infected SK-N-SH cells at levels
similar to those observed in cells infected with wild-type
marker rescue viruses (e.g., HSV-1 17termAR [Bolovan
et al., 1994] or HSV-1 34.5D68–87R) in contrast to the
marked host-cell shutoff observed in cells infected with
HSV-1 17termA (Figure 4D). Together, these results dem-
onstrate that amino acids 68–87 of ICP34.5 are dispens-
able for productive viral replication and inhibition of eIF2a
phosphorylation and host-cell shutoff in SK-N-SH cells.
The Beclin 1-Binding-Deficient ICP34.5 Mutant Virus
Is Defective in Autophagy Inhibition in Neurons
To evaluate whether HSV-1 34.5D68–87 can inhibit au-
tophagy, we performed EM analyses of primary sympa-
thetic neurons infected with HSV-1 34.5D68–87, HSV-1
34.5D68–87R, and HSV-1 17termA. We chose to use neu-
rons because they are a natural target for HSV-1 infection
in vivo, and previously we showed that HSV-1 lacking the
entire ICP34.5 gene (HSV-1 17termA), but not wild-type
HSV-1, induces autophagy in primary sympathetic
neurons (Tallo´czy et al., 2006). We found that HSV-128 Cell Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier In34.5D68–87R-infected neurons (Figure 5A, upper right
panel) exhibit levels of autophagy indistinguishable from
those of mock-infected neurons (Figure 5A, upper left
panel) (Figure 5B). In contrast, neurons infected with either
the full ICP34.5 deletion mutant virus (HSV-1 17termA;
Figure 5A, lower left panel) or the Beclin 1-binding-defi-
cient ICP34.5 deletion mutant virus (HSV-1 34.5D68–87;
Figure 5A, lower right panel) have significantly higher
levels of autophagosome accumulation (p < 0.0001 for
both mutants versus HSV-1 34.5D68–87R, Student’s
t test) (Figure 5B). These results, together with our results
in neuroblastoma cells, demonstrate that ICP34.5 binds
Beclin 1 and inhibits virus-induced autophagy in neurons
and that this activity is independent from its role in antag-
onizing host-cell shutoff.
The Beclin 1-Binding-Deficient ICP34.5 Mutant Virus
Is Neuroattenuated In Vivo
Our data with HSV-1 34.5D68–87 indicate that the Beclin
1-binding region of ICP34.5 is necessary for autophagy in-
hibition but not for ICP34.5-mediated blockade of host-
cell translational arrest. To evaluate the significance of
ICP34.5 antagonism of Beclin 1 function in viral neuropa-
thogenesis, we compared the mortality of C57BL/6J mice
infected intracerebrally with 5 3 105 pfu of either HSV-1
34.5D68–87 or HSV-1 34.5D68–87R (Figure 6A). Nearly
80% of mice succumbed to lethal HSV-1 34.5D68–87R in-
fection within 10 days, whereas only 15% of mice infected
with HSV-1 34.5D68–87 died within a 21 day observation
period (p < 0.0001, log-rank test).
Consistent with reduced mortality, we observed a strik-
ing defect in viral replication in the brains of mice infected
with HSV-1 34.5D68–87 (Figure 6B). Viral titers were sim-
ilar in the brains of mice infected with HSV-1 34.5D68–87c.
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of ICP34.5 Is Required for Inhibition of
Autophagy in Neurons
(A) Representative electronmicrographs of pri-
mary sympathetic neurons infected with the in-
dicated virus. Arrows denote representative
autophagosomes that would be scored as
positive in (B). Scale bars, 1 mm.
(B) Quantitation of the number of autophago-
somes per cell profile in primary sympathetic
neurons infected with the indicated virus. Re-
sults shown represent mean value ± SEM for
50 cells per experimental condition.and HSV-1 34.5D68–87R at day 1 after infection. How-
ever, levels of infectious virus declined below the limit of
detection within 5 days after infection in the brains of
mice infected with HSV-1 34.5D68–87. In contrast, signif-
icant levels of infectious virus were recovered in the brains
of mice infected with HSV-1 34.5D68–87R for at least 5
days, after which time the majority of mice succumbed
to lethal disease.
Histopathological analyses of the brains of mice at days
1, 3, and 5 after infection revealed leptomeningeal, peri-
vascular, and parenchymal inflammation (especially in
the basal ganglia, brainstem, and hippocampus) in mice
infected with both the HSV-1 34.5D68–87 and HSV-1
34.5D68–87R viruses, but the degree of parenchymal
inflammation was more severe in mice infected with
HSV-1 34.5D68–87R (Figure 6C, left panels, and data not
shown). Very few HSV-1 immunoreactive neurons were
observed in the brains of HSV-1 34.5D68–87-infected
mice, whereas large regions of HSV-1 immunoreactiveCelneurons were observed in the brains of HSV-1 34.5D68–
87R-infected mice (Figure 6C, right panels). Furthermore,
in HSV-1 34.5D68–87R-infected brains, there were nu-
merous neurons with pyknotic nuclei and eosinophilic
cytoplasm, whereas neuronal pathology was rarely ob-
served in HSV-1 34.5D68–87-infected mice (Figure 6C,
left panels). Thus, the brains of mice infected with HSV-1
34.5D68–87R demonstrate significantly more neuropa-
thology than the brains of mice infected with HSV-1
34.5D68–87. Taken together, the mortality studies, CNS
viral replication studies, and CNS histopathological analy-
ses demonstrate that the Beclin 1-binding-deficient mu-
tant virus is highly neuroattenuated in vivo.
Restoration of Neurovirulence of the Beclin
1-Binding-Deficient ICP34.5 Mutant Virus
in Mice with a Homozygous Deletion in pkr
Previously, we have shown that PKR signaling is required
for autophagy induction and autophagy-dependent virionl Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inc. 29
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Autophagy Inhibition and HSV-1 NeurovirulenceFigure 6. An HSV-1 Recombinant Virus Containing a Mutation in ICP34.5 that Abrogates Binding to Beclin 1 Is Neuroattenuated
In Vivo
(A) Survival of C57BL/6Jmice infected intracerebrally with 53 105 pfu of either HSV-1 34.5D68–87 or itsmarker rescue (HSV-1 34.5D68–87R). Results
shown represent survival data combined from four independent infections. Similar results were observed in each experiment.
(B) Viral replication of HSV-1 34.5D68–87 and HSV-1 34.5D68–87R in brain tissue of infected mice at indicated time after infection. Lower limit of
detection = 1.7. Data shown represent mean ± SEM geometric titer for seven to ten mice per experimental group per time point.
(C) Representative images of H&E staining (left panels) and HSV-1 antigen staining (right panels) in basal ganglia from mice infected with HSV-1
34.5D68–87R (upper panels) or HSV-1 34.5D68–87 (bottom panels) on day 5 postinfection. Arrows in upper left panel indicate eosinophilic, necrotic
neurons with pyknotic nuclei. Scale bars, 50 mm in left panels and 200 mm in right panels.degradation in murine embryonic fibroblasts (MEFs) and
sympathetic neurons (Tallo´czy et al., 2002, 2006). These
findings raise the possibility that PKR signaling may lie ge-
netically upstream of Beclin 1-dependent autophagy in
HSV-1 antiviral host defense. To investigate this possibil-
ity, we evaluated whether the neurovirulence of the Beclin
1-binding ICP34.5 mutant virus is restored in 129 Ev/Sv
mice containing a null mutation in pkr (herein referred to
as pkr/ mice).30 Cell Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier InConsistent with previously described mouse strain dif-
ferences in susceptibility to HSV-1 infection (Kirchner
et al., 1978), we found that 129 Ev/Sv mice are more sus-
ceptible to fatal HSV-1 infection than C57BL/6J mice
(Figure 7A). However, similar to our findings in C57BL/6J
mice, the HSV-1 34.5D68–87 mutant virus also results in
significantly less mortality in wild-type 129 Ev/Sv mice as
compared to the marker rescue control virus (Figure 7A;
p < 0.0001, log rank test). In contrast, in pkr/ mice, thec.
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of a Beclin 1-Binding-Deficient Virus in
pkr/ Mice
(A) Survival of wild-type 129 Ev/Sv mice in-
fected intracerebrally with 13 105 pfu of either
HSV-1 34.5D68–87 or its marker rescue
(HSV-1 34.5D68–87R). (B) Survival of 129
Ev/Sv pkr/ mice infected intracerebrally
with 1 3 105 pfu of either HSV-1 34.5D68–87
or its marker rescue (HSV-1 34.5D68–87R).
(A and B) Results shown represent survival
data combined from two to three independent
infections. Similar results were observed in
each experiment. (C) Viral replication of HSV-1
34.5D68–87 and HSV-1 34.5D68–87R in brain
tissue of infected 129 Ev/Sv mice at indicated
time after infection. (D) Viral replication of
HSV-1 34.5D68–87 and HSV-1 34.5D68–87R
in brain tissue of infected 129 Ev/Sv pkr/
mice at indicated time after infection. For (C)
and (D), data shown represent mean ± SEM
geometric titer for three to five mice per exper-
imental group per time point.mortality of mice infected with HSV-1 34.5D68–87 was as
high as the mortality of mice infected with HSV-1
34.5D68–87R (Figure 7B). Furthermore, in wild-type
mice, HSV-1 34.5D68–87 replication in brain is signifi-
cantly lower than HSV-1 34.5D68–87R replication (and
HSV-1 34.5D68–87 infectious virus is gradually cleared)
(Figure 7C), whereas in pkr/ mice, HSV-1 34.5D68–87
replicates in brain to levels similar to those observed
during infection with HSV-1 34.5D68–87R (Figure 7D). To-
gether, these findings demonstrate that pkr deletion
in vivo restores the virulence of the Beclin 1-binding-defi-
cient ICP34.5 mutant virus. These findings suggest that
PKR induction of Beclin 1-dependent autophagy is impor-
tant for protection against HSV-1 encephalitis.
DISCUSSION
Here we provide evidence that an essential HSV-1 neuro-
virulence factor, ICP34.5, confers pathogenicity by bind-
ing to the mammalian autophagy protein Beclin 1 and an-
tagonizing the host autophagy response. To the best of
our knowledge, these findings represent the first descrip-
tion of a microbial virulence factor directly antagonizing
the host autophagy machinery to elicit disease. Previous
studies have demonstrated that certain bacterial and viral
gene products can antagonize host autophagy in vitro.
During Shigella infection, the bacterial encoded virulence
factor IcsB blocks the induction of autophagy by VirG
(Ogawa et al., 2005). In addition, viral Bcl-2 proteins en-
coded by the oncogenic g-herpesviruses block autoph-Ceagy induction by binding to Beclin 1 (Pattingre et al.,
2005; Liang et al., 2006). However, in these examples,
the significance of microbial antagonism of host autoph-
agy in disease pathogenesis is not yet known. Our finding
that the Beclin 1-binding domain of the HSV-1-encoded
neurovirulence protein ICP34.5 is essential for lethal
HSV-1 encephalitis demonstrates the importance of mi-
crobial evasion of autophagy in disease pathogenesis.
The requirement for HSV-1-mediated inhibition of au-
tophagy in the pathogenesis of viral encephalitis provides
strong evidence that autophagy is an important mecha-
nism of innate immunity in vivo. Several studies have
shown that autophagy genes restrict intracellular bacterial
growth in cultured cells (Levine, 2005; Deretic, 2006;
Amano et al., 2006); however, the role of autophagy
in host defense against intracellular bacterial infections
in vivo is not yet known. A previous study showed that en-
forced neuronal expression of Beclin 1 decreases Sindbis
virus CNS replication, decreases Sindbis virus-induced
neuronal apoptosis, and protectsmice against lethal Sind-
bis virus encephalitis (Liang et al., 1998), raising the possi-
bility that Beclin 1-dependent autophagymay play a role in
innate antiviral immunity. In this study, we demonstrate
that the Beclin 1-binding and autophagy-inhibitory domain
of HSV-1 ICP34.5 is essential for neurological disease.
This observation suggests that autophagy is an important
mechanism of innate immunity that must be successfully
countered for certain viruses to be pathogenic.
As a corollary, viral evasion of autophagy likely repre-
sents an important strategy that viruses use to outsmartll Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inc. 31
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HSV-1 ICP34.5 is required for neurovirulence (Chou
et al., 1990; Harrow et al., 2004), that ICP34.5 blocks
PKR-dependent autophagy (Tallo´czy et al., 2002, 2006),
and that blockade of PKR-dependent functions in vivo is
essential for HSV-1 neurovirulence (Leib et al., 2000).
However, since PKR activation also results in translational
arrest in virally infected cells, the significance of the au-
tophagy-inhibitory effects of ICP34.5 in viral virulence
has been unclear. Our studies permitted us to genetically
dissect the role of ICP34.5-mediated inhibition of autoph-
agy in viral virulence from ICP34.5-mediated antagonism
of other PKR-dependent functions by constructing a re-
combinant mutant virus that retains its GADD34 domain
and ability to block PKR-dependent translational arrest
but is defective in Beclin 1 binding and inhibition of au-
tophagy in virally infected neurons. This mutant virus is
highly neuroattenuated in vivo, suggesting that ICP34.5-
mediated blockade of host-cell shutoff is not sufficient
to confer neurovirulence but rather that ICP34.5-mediated
blockade of Beclin 1-dependent autophagy is required for
neurovirulence. Moreover, our findings in mice lacking
pkr/, demonstrating restoration of neurovirulence of a
mutant strain of HSV-1 that is specifically impaired in Be-
clin 1-binding and autophagy-inhibitory activity, indicate
that PKR lies genetically upstream of Beclin 1 in antiviral
host defense in vivo. Since PKR is targeted by virulence
factors encoded bymany different viruses, including other
medically important pathogens such as hepatitis C virus
and influenza virus (Katze et al., 2002), it will be of interest
to determine the role of autophagy evasion in the patho-
genesis of diseases caused by such viruses.
One important question that arises is why ICP34.5 pos-
sesses two separate mechanisms for blocking host-cell
autophagy, including blockade of PKR-dependent signal-
ing and blockade of Beclin 1 function. Although we have
previously shown that cells require pkr and the serine 51
phosphorylation site of eIF2a to undergo virus-induced
autophagy (Tallo´czy et al., 2002), it is possible that very
low levels of phosphorylated eIF2a are sufficient to trigger
autophagy in HSV-1-infected wild-type cells. If so, suc-
cessful inhibition of autophagy may require a second
mechanism, such as blocking a downstream autophagy
effector protein. Indeed, we found that the GADD34
domain of ICP34.5, which is sufficient to antagonize
PKR-dependent translational arrest, is not required to
block autophagy in mammalian cells, whereas the Beclin
1-binding domain of ICP34.5 is required for autophagy
inhibition. Thus, antagonism of PKR signaling, in the ab-
sence of antagonism of Beclin 1 function, is not sufficient
to block host-cell autophagy (even though PKR and eIF2a
serine 51 phosphorylation are required for autophagy
induction).
The mechanism by which ICP34.5 inhibits Beclin 1-
dependent autophagy is not yet known. Two major lines
of evidence suggest that the binding of ICP34.5, either
directly or indirectly, to Beclin 1 is required for its autoph-
agy-inhibitory function. First, ICP34.5 fails to interact with
the yeast ortholog Atg6 and has no inhibitory effect on32 Cell Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inthe ability of ATG6 transformation to rescue autophagy
in atg6 null yeast. In contrast, ICP34.5 binds to Beclin 1
in yeast and blocks the ability of beclin 1 to rescue au-
tophagy in atg6 null yeast. Second, in mammalian cells,
we observed a direct correlation between the ability of
different mutants of ICP34.5 to coimmunoprecipitate
with Beclin 1 and the ability to inhibit Beclin 1-dependent
autophagy. Interestingly, the domain of Beclin 1 required
for interacting with ICP34.5 appears to be distinct from
that involved in binding to cellular and viral Bcl-2-like pro-
teins or in binding to the class III PI3 kinase Vps34 (Liang
et al., 1999; Pattingre et al., 2005; Furuya et al., 2005; and
data not shown). Therefore, it is unlikely that ICP34.5 di-
rectly competes with Vps34 for binding to Beclin 1. More-
over, the lack of any structural similarity between HSV-1
ICP34.5 and g-herpesvirus-encoded Bcl-2 proteins, cou-
pled with the lack of conservation in regions of Beclin 1
required for binding to these proteins, indicates that dif-
ferent families of herpesviruses may have evolved diverse
strategies to antagonize Beclin 1 activity in virally infected
cells. The utilization of diverse strategies to target the
same host autophagy protein by different virus families
underscores the likely importance of Beclin 1 antagonism
in viral pathogenesis and the likely importance of Beclin
1-dependent autophagy in antiviral host defense.
Beclin 1-dependent autophagy may function in antiviral
host defense by several different mechanisms. There is
now increasing evidence that cytoplasmic bacteria are
targeted for lysosomal degradation by an autophagy
gene-dependent pathway (xenophagy) (Levine, 2005;
Amano et al., 2006), and it seems likely that a similar path-
way is involved in the degradation of intracytoplasmic
virions. Indeed, we previously found that HSV-1 virions
are degraded inside autophagosomes in MEFs and in pri-
mary cultured neurons (Tallo´czy et al., 2006). Based upon
our CNS replication studies with the Beclin 1-binding-de-
ficient ICP34.5mutant virus, we speculate that xenophagy
may also function to restrict HSV-1 replication in virally in-
fected neurons in vivo. Autophagy may also play a direct
role in promoting neuronal survival during viral infection.
In support of this hypothesis, autophagy genes protect
against programmed cell death in plant cells infected
with tobacco mosaic virus (Liu et al., 2005), in mouse neu-
rons infected with Sindbis virus (Liang et al., 1999), and in
neurons subjected to noninfectious forms of cellular stress
(Levine and Yuan, 2005).
It is interesting to note that basal autophagy in the
mouse nervous system is critical to ensure protein quality
control and the prevention of neurodegenerative dis-
eases. Conditional deletion of either atg5 or atg7 in the
central nervous system results in progressive accumula-
tion of intraneuronal inclusion bodies, leading to neurode-
generation and motor deficits (Hara et al., 2006; Komatsu
et al., 2006). Accordingly, it is possible that ICP34.5-medi-
ated antagonism of autophagy may not only promote viral
replication, increase neuronal death, and increase animal
mortality during acute HSV-1 encephalitis, but also con-
tribute to chronic cellular dysfunction in the neurons of
survivors.c.
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host interaction that is required to elicit fatal neurological
disease. An essential function of the virulence factor
HSV-1 ICP34.5 is to target the host autophagy machinery
component Beclin 1. Genetic disruption of PKR, an au-
tophagy-inducing signalingmolecule, completely restores
the neurovirulence of an autophagy-inhibitory-defective
mutant virus. These findings provide evidence that au-
tophagy plays an important role in protection against viral
infection and that successful viral evasion of autophagy
plays a key role in disease pathogenesis.
EXPERIMENTAL PROCEDURES
Yeast Strains, Expression Vectors, and Assays
The atg6-disruped S. cerevisiae strain JCY3000 and wild-type strain
SFY526 have been previously described (Seaman et al., 1997; Liang
et al., 1998). For yeast two-hybrid studies, previously described plas-
mids were used, including full-length human beclin 1 (1–1350 bp), a C-
terminal truncation mutant of human beclin 1 (1–708 bp), or yeast
ATG6 cloned into the GAL4 activation domain plasmid pGAD424
(Liang et al., 1998, 1999). The full-length open reading frame of HSV-
1 strain F ICP34.5 cloned into pGBT9 b-galactosidase domain plasmid
was provided byBernard Roizman. Yeast two-hybrid analyses of these
plasmids was performed in SFY526 cells as described (Liang et al.,
1998). For autophagy studies, yeast expression vector constructs in-
cluded empty vector pMS424, pMS424 encoding human beclin 1
(Liang et al., 1999), pMS424 encoding S. cerevisiae ATG6 (Seaman
et al., 1997), empty vector pGPD426, and pGPD426 encoding HSV-1
strain 17 ICP34.5. Yeast autophagy was measured in JCY3000 cells
during nitrogen starvation conditions by quantitative DIC microscopy
as previously described (Liang et al., 1999, Tallo´czy et al., 2002).
Mammalian Cell Lines
HEK293, MCF7, and SK-N-SH cell lines were obtained from the Amer-
ican Type Culture Collection (ATCC) and maintained according to
ATCC instructions. The construction and maintenance of MCF7 cell
lines stably transfected with tetracycline-repressible Flag-beclin 1
has been previously described (Liang et al., 2001). Mouse beclin 1/
and beclin 1+/+ ES cells were provided by Nathaniel Heintz and cul-
tured as described (Yue et al., 2003). ES cells were cultured without
MEF feeder layers before experiments to ensure homogenous ES
cell populations. Primary sympathetic neuron cultures were prepared
from superior cervical ganglia of postnatal day 2 129 Ev/Sv mice using
a modification of a previously described protocol (Easton et al., 1997).
Virus Strains
The HSV-1 ICP34.5 deletion mutant (17termA) and its marker-rescued
virus (17termAR) were made in the background of strain 17 of HSV-1
and have been previously described (Bolovan et al., 1994; Leib et al.,
2000). To construct an HSV-1 virus lacking the nucleotides encoding
amino acids 68–87 of HSV-1 (termed HSV-1 ICP34.5D68–87) and its
marker rescue control (HSV-1 ICP34.5D68–87R), we used our previ-
ously published BAC method (Gierasch et al., 2006). Please refer to
Figure S1 for a schematic diagram and to the Supplemental Experi-
mental Procedures for details of the construction of these viruses.
Viral Growth Curves
Viral growth in SK-N-SH neuroblastoma cells was measured during in-
fection with HSV-1 34.5D68–87 or HSV-1 34.5D68–87R at an MOI of
0.01 pfu/cell by performing plaque assay titration of freeze-thawed ly-
sates on Vero cells. For in vivo viral replication studies, mice were sac-
rificed at the indicated time points after infection, and frozen brain tis-
sue homogenates were used for plaque assay titration on Vero cells.CeCoimmunoprecipitation and Western Blot Analyses
For coimmunoprecipitation studies, HEK293 cells were cotransfected
with pCR3.1 plasmids expressing N-terminal Flag epitope-tagged
Beclin 1 and ICP34.5, and MCF7.beclin 1 cells were transfected with
C-terminal Myc-tagged HSV-1 strain 17 ICP34.5 full-length or deletion
mutants using Lipofectamine 2000 (Invitrogen) according to the man-
ufacturer’s instructions. Coimmunoprecipitation of virally expressed
ICP34.5 and endogenous Beclin 1 was performed on SK-N-SH and
ES cells infected with the indicated virus at an MOI of 5. Beclin 1
was immunoprecipitated and detected in Western blot analyses using
either anti-Flag (HEK293 cells, MCF7.beclin 1 cells) (Sigma F3165;
1:100 dilution) or anti-Beclin 1 (Novus Biologicals or Santa Cruz;
1:100 dilution), and ICP34.5 was detected in cell lysates and coimmu-
noprecipitates using either anti-Myc (MCF7.beclin 1 cells) (Novus
ab9106; 1:10,000 dilution) or a rabbit polyclonal anti-ICP34.5 antibody
raised against GST-purified N-terminal 69 amino acids of the Patton
strain 34.5 protein (HEK293 cells, ES cells, SK-N-SH cells) (generously
provided by I. Mohr; 1:1000 dilution). EIF2a phosphorylation in SK-N-
SH was detected by Western blot analysis as described previously
(Tallo´czy et al., 2002) using anti-phospho-specific eIF2a Ab (1:100
dilution) (Research Genetics). Please refer to the Supplemental Exper-
imental Procedures for details of lysis conditions for coimmunoprecipi-
tation experiments.
Mammalian Cell Autophagy Assays
Quantitative GFP-LC3 light microscopy autophagy assays were per-
formed inMCF7.beclin 1 cells cotransfected with a GFP-LC3-express-
ing plasmid, pEGFP-C1 (Kabeya et al., 2000), and a pCR3.1 construct
expressing full-length or deletion mutants of C-terminal Myc-tagged
HSV-1 strain 17 ICP34.5 as described (Pattingre et al., 2005). Quanti-
tative EM autophagy assays were performed as previously described
(Tallo´czy et al., 2002) in primary sympathetic neurons pretreated with
100 IU/ml recombinant mouse IFN-a (Sigma) for 18 hr, infected with
HSV-1 17termA, HSV-1 34.5D68–87, or HSV-1 34.5D68–87R at an
MOI of 5, and fixed 24 hr after infection.
Host-Cell Shutoff Assays
Host-cell shutoff assays were performed as previously described
(Chou and Roizman, 1992), using SK-N-SH cells infected at an MOI
of 5 and incubated at 16 hr after infection with [35S]methionine (specific
activity 1175 Ci/mmol; 1Ci = 43.5 TBq; MP Biomedicals, Inc) for 1.5 hr
in media lacking methionine.
Animal Experiments
Four- to eight-week-old C57BL/6J mice (Jackson Laboratory), and
pkr/ or wild-type 129 Ev/Sv backcrossed control mice (Leib et al.,
2000) of either sex were used in all studies. For HSV-1 encephalitis
mortality studies, mice were anesthetized, injected intracerebrally
with 1–5 3 105 pfu of virus in 30 ml HBSS, and followed daily for 3
weeks for survival. All animal procedures were performed in accor-
dance with Institutional Animal Use and Care Committee policies.
Histopathological Analyses
At serial time points after infection, mice were euthanized, and the left
cerebral hemispheres were fixed by immersion in 4% paraformalde-
hyde. Serial paraffin-embedded sections were stained with H&E and
subjected to immunohistochemical analysis using a rabbit polyclonal
antibody to HSV-1 (1:6000 dilution) in conjunction with a MACH 4 Uni-
versal HRP-polymer detection system (Dako).
Supplemental Data
The Supplemental Data include Supplemental Experimental Proce-
dures and one supplemental figure and can be found with this article
online at http://www.cellhostandmicrobe.com/cgi/content/full/1/1/
23/DC1/.ll Host & Microbe 1, 23–35, March 2007 ª2007 Elsevier Inc. 33
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